The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems

Obesity (Ob) poses a significant risk factor for the onset of metabolic syndrome with associated complications, wherein the Mesenchymal Stem Cell (MSC) therapy shows pre-clinical success. Here, we explore the therapeutic applications of human Placental MSCs (P-MSCs) to address Ob-associated Insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotikalapudi, Nagasuryaprasad, Sampath, Samuel Joshua Pragasam, Sukesh Narayan, Sinha, R., Bhonde, Nemani, Harishankar, Mungamuri, Sathish Kumar, Venkatesan, Vijayalakshmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379204/
https://www.ncbi.nlm.nih.gov/pubmed/34417511
http://dx.doi.org/10.1038/s41598-021-96121-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379204/
https://www.ncbi.nlm.nih.gov/pubmed/34417511
http://dx.doi.org/10.1038/s41598-021-96121-0

Ejemplares similares